title: Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives.
abstract: Head and neck squamous cell cancer (HNSCC) is the sixth most common cancer in the world. Effective therapeutic modalities such as surgery, radiation, chemotherapy and combinations of each are used in the management of the disease. In most cases, treatment fails to obtain total cancer cure. In recent years, it appears that one of the key determinants of treatment failure may be the presence of cancer stem cells (CSCs) that escape currently available therapies. CSCs form a small portion of the total tumor burden but may play a disproportionately important role in determining outcomes. CSCs have stem features such as self-renewal, high migration capacity, drug resistance, high proliferation abilities. A large body of evidence points to the fact that CSCs are particularly resistant to radiotherapy and chemotherapy. In HNSCC, CSCs have been increasingly shown to have an integral role in tumor initiation, disease progression, metastasis and treatment resistance. In the light of such observations, the present review summarizes biological characteristics of CSCs in HNSCC, outlines targeted strategies for the successful eradication of CSCs in HNSCC including targeting the self-renewal controlling pathways, blocking epithelial mesenchymal transition, niche targeting, immunotherapy approaches and highlights the need to better understand CSCs biology for new treatments modalities.
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Benoîte
authors.initials: B
authors.lastname: Méry
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Jean-Baptiste
authors.initials: JB
authors.lastname: Guy
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Espenel
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Wozny
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Simonet
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Alexis
authors.initials: A
authors.lastname: Vallard
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Gersende
authors.initials: G
authors.lastname: Alphonse
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Dominique
authors.initials: D
authors.lastname: Ardail
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Rodriguez-Lafrasse
authors.affiliation: Benoîte Méry, Jean-Baptiste Guy, Sophie Espenel, Alexis Vallard, Nicolas Magné, Department of Radiotherapy, Lucien Neuwirth Cancer Institute, 42271 Saint-Priest en Jarez, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Magné
keywords: Biology; Chemotherapy; Head and neck neoplasms; Molecular targeted therapy; Neoplastic stem cells; Oral cancer; Radiation therapy
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2871-5
references.pmid: 18539966
references.citation: Cancer Res. 2012 Jun 1;72(11):2844-54
references.pmid: 22552285
references.citation: J Dent Res. 2012 Apr;91(4):334-40
references.pmid: 21933937
references.citation: Stem Cells. 2013 Mar;31(3):423-32
references.pmid: 23193035
references.citation: Biochem Biophys Res Commun. 2009 Jul 31;385(3):307-13
references.pmid: 19450560
references.citation: Stem Cell Rev. 2014 Feb;10(1):114-26
references.pmid: 23955575
references.citation: PLoS One. 2008;3(10):e3360
references.pmid: 18852874
references.citation: Clin Cancer Res. 2011 Oct 1;17(19):6174-84
references.pmid: 21856769
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12425-30
references.pmid: 21746895
references.citation: J Clin Invest. 2004 Jan;113(2):175-9
references.pmid: 14722607
references.citation: J Nucl Med. 2000 Dec;41(12):1999-2010
references.pmid: 11138685
references.citation: PLoS One. 2011 Jan 27;6(1):e16466
references.pmid: 21304586
references.citation: J Cancer Res Clin Oncol. 2013 Jan;139(1):159-70
references.pmid: 23001491
references.citation: Cancer Res. 2007 Nov 1;67(21):10538-45
references.pmid: 17974998
references.citation: Oral Oncol. 2009 Jul;45(7):633-9
references.pmid: 19027347
references.citation: J Oncol. 2011;2011:941876
references.pmid: 20981352
references.citation: FASEB J. 2007 Dec;21(14):3777-85
references.pmid: 17625071
references.citation: Nat Med. 2004 Jan;10(1):55-63
references.pmid: 14702635
references.citation: J Natl Cancer Inst. 2006 Dec 20;98 (24):1755-7
references.pmid: 17179471
references.citation: Oncogene. 2010 Apr 8;29(14):2047-59
references.pmid: 20101235
references.citation: Clin Dev Immunol. 2010;2010:701657
references.pmid: 21437225
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: J Biol Chem. 2010 Feb 5;285(6):4060-73
references.pmid: 19965872
references.citation: Nat Cell Biol. 2004 Oct;6(10 ):931-40
references.pmid: 15448698
references.citation: Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1260-6
references.pmid: 21173377
references.citation: Clin Cancer Res. 2010 Jun 15;16(12):3153-62
references.pmid: 20530697
references.citation: Cancer Res. 2013 Feb 1;73(3):1128-41
references.pmid: 23221383
references.citation: J Immunol. 2012 Jul 1;189(1):444-53
references.pmid: 22664874
references.citation: Cancer Lett. 2010 Mar 28;289(2):151-60
references.pmid: 19748175
references.citation: Nature. 2010 Jul 1;466(7302):133-7
references.pmid: 20596026
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8
references.pmid: 17210912
references.citation: Oral Oncol. 2010 Mar;46(3):158-65
references.pmid: 20036608
references.citation: Cancer Res. 2007 Apr 15;67(8):3560-4
references.pmid: 17440065
references.citation: J Oral Pathol Med. 2007 Nov;36(10 ):594-603
references.pmid: 17944752
references.citation: Cancer Res. 2010 Dec 1;70(23):9969-78
references.pmid: 21098716
references.citation: J Cell Biochem. 2008 Feb 1;103(2):408-12
references.pmid: 17546610
references.citation: Mol Cancer Ther. 2010 Nov;9(11):2879-92
references.pmid: 21062915
references.citation: Anticancer Res. 2013 Mar;33(3):747-54
references.pmid: 23482741
references.citation: Nat Cell Biol. 2010 Oct;12 (10 ):982-92
references.pmid: 20818389
references.citation: Oncotarget. 2010 Nov;1(7):552-66
references.pmid: 21317452
references.citation: Cancer. 2008 Aug 15;113(4):750-7
references.pmid: 18536030
references.citation: Semin Cancer Biol. 2010 Apr;20(2):77-84
references.pmid: 20371287
references.citation: Cancer Res. 2013 Jun 1;73(11):3425-40
references.pmid: 23548270
references.citation: Br J Cancer. 2007 Dec 3;97(11):1545-51
references.pmid: 17987038
references.citation: Cancer Res. 2006 Feb 15;66(4):1883-90; discussion 1895-6
references.pmid: 16488983
references.citation: Int J Dev Biol. 2011;55(4-5):477-82
references.pmid: 21732274
references.citation: Head Neck. 2009 Jan;31(1):94-101
references.pmid: 18853445
references.citation: Eur Arch Otorhinolaryngol. 2009 May;266(5):735-44
references.pmid: 18839197
references.citation: J Dent Res. 2011 May;90(5):638-45
references.pmid: 21220361
references.citation: Laryngoscope. 2011 Mar;121(3):527-33
references.pmid: 21344428
references.citation: J Biol Chem. 2010 Nov 19;285(47):36995-7004
references.pmid: 20826811
references.citation: Int J Cancer. 2011 Nov 15;129(10):2337-48
references.pmid: 21225626
references.citation: Clin Cancer Res. 2010 Jun 15;16(12):3106-12
references.pmid: 20530695
references.citation: Clin Exp Metastasis. 2013 Aug;30(6):781-91
references.pmid: 23519726
references.citation: Blood. 1997 Dec 15;90(12):5002-12
references.pmid: 9389720
references.citation: CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
references.pmid: 21685461
references.citation: Dev Biol. 2003 Jun 15;258(2):406-18
references.pmid: 12798297
references.citation: PLoS One. 2010 Jul 06;5(7):e11456
references.pmid: 20625515
references.citation: Nat Rev Cancer. 2008 Oct;8(10):755-68
references.pmid: 18784658
references.citation: Head Neck. 2010 Oct;32(10):1302-9
references.pmid: 20091690
references.citation: Annu Rev Med. 2007;58:267-84
references.pmid: 17002552
references.citation: Blood. 2012 Jun 7;119(23):5492-501
references.pmid: 22529286
references.citation: Cancer Res. 2012 Apr 1;72(7):1853-64
references.pmid: 22473314
references.citation: Clin Cancer Res. 2002 Aug;8(8):2553-62
references.pmid: 12171883